Lysophosphatidylcholine (LPC) accumulates in ischemic tissue, and exogenous LPC (20-100 MM) induces electrophysiologic alterations in vitro. However, to determine whether compartmentalization is critical, intracellular pressure microinjection of LPC was performed with simultaneous recording of the transmembrane action potential. Intracellular LPC in concentrations as high as 500 AM (n = 18), calculated based on calibration of injectate volume and cellular volume, did not induce electrophysiologic alterations. The concentrations and efflux of phospholipids and lysophospholipids were assessed in lymph obtained from the supracardiac lymph vessel in anesthetized dogs to assess the extent of extracellular accumulation. Prior to ischemia, phosphatidylcholine (PC) was the major phospholipid in lymph (79±2%) with substantial quantities of sphingomyelin (11±2%) and LPC (6±1%). With ischemia, the concentration of LPC increased by 18%, and net efflux of LPC increased by 24% (P < 0.01) with no net efflux of PC or other assayed phospholipids. The calculated concentration of LPC increased from 84 to 197 MM in lymph within the ischemic region, a concentration sufficient to induce electrophysiologic derangements.
Introduction
Lethal arrhythmias induced by myocardial ischemia account for most deaths attributable to coronary artery disease (1) . In experimental animals, such arrhythmias can occur early after the onset of ischemia and well before morphologic alterations appear in tissue. Metabolites accumulating in ischemic myocardium appear to influence membrane integrity and to mediate many of the electrophysiologic derangements characteristically seen with ischemia in vivo (2, 3) . Lysophosphoglycerides have been found to accumulate in samples of ischemic tissue in vivo, in venular effluents from ischemic regions in vivo, and in effluents from isolated hearts rendered ischemic (4) (5) (6) (7) . Net changes in the concentration oflysophosphatidylcholine (LPC)' in tissue comparable to those seen in ischemic tissue in vivo induce analogous, reversible electrophysiologic derangements in normoxic 1 . Abbreviations used in this paper: DMA, dimethylacetal; FAME, fatty acid methyl esters; LAD, left anterior descending (coronary artery); LPC, lysophosphatidylcholine; PC, phosphatidylcholine; TLC, thin-layer chromatography.
tissue in vitro (7) (8) (9) (10) (11) (12) . Electron microscopic autoradiography demonstrates that incorporation of ['4C ]LPC comprising <2 mol % of sarcolemmal phospholipid is sufficient to elicit profound electrophysiologic derangements in isolated ventricular muscle (13, 14) . Because sarcolemmal phospholipid comprises only 4% of total cellular phospholipid, even very modest increases of total cellular LPC are likely to be arrhythmogenic if lysophosphoglycerides accumulate selectively in the cell membrane, as appears to be the case (15) .
Sites of enhanced production or decreased catabolism accounting for accumulation of lysophosphoglycerides with ischemia have not yet been elucidated. Some of the accumulation may be intracellular. Previous studies have characterized the electrophysiologic effects induced by lysophosphoglycerides delivered extracellularly (7) (8) (9) (10) 12 ). However, it is not clear whether increased intracellular concentrations of lysophosphoglycerides result in analogous electrophysiologic alterations. Some of the accumulation appears to be extracellular. The concentration of LPC increases within 10 min after the onset of ischemia in venular effluents from ischemic zones (5) . Ifa proportionality exists between concentrations in plasma and in interstitial fluid, lysophosphoglycerides may be impinging on the external surface of sarcolemma. In ischemic isolated perfused hearts (4), the concentrations of lysophosphoglycerides increase in effluents as well as in tissue, compatible with either release into the interstitial fluid of intracellularly accumulated material or with direct, extracellular accumulation. In addition, early reperfusion rapidly reverses the electrophysiologic derangements induced by ischemia (3) . This observation is consistent with the view that at least some of the accumulating lysophosphoglycerides may be extracellular. Although lymph is not identical to tissue fluid, concentrations of specific moieties in lymph often parallel concentrations in compartments with direct access to the sarcolemma and may reflect metabolic activity at the cell surface (16, 17) .
In view of these considerations, the present study was performed to determine whether augmentation of the intracellular concentration of LPC elicited by pressure microinjection induces electrophysiologic alterations analogous to changes induced by increased concentrations of extracellular lysophosphoglycerides. It was performed also to determine whether characteristic changes in the concentrations of extracellular lysophosphoglycerides occur with ischemia in vivo judging from assay of lymph draining zones subjected to ischemia.
Methods
Electrophysiologic procedures. Adult mongrel dogs ofeither gender were anesthetized with sodium thiopental (10 mg/kg), and the hearts were rapidly removed and placed in oxygenated Krebs solution. Purkinje fibers were dissected from both the right and left ventricles. For the pressure microinjection studies, it was essential to utilize small, thin Purkinje fibers to minimize changes in the microelectrode tip resistance otherwise encountered when cells were penetrated. The fibers were attached to small glass coverslips with a pin, placed in a 5-ml plexiglass chamber located on the stage of a Nikon microscope (Nikon, Inc., Garden City, NY) and superfused continuously with modified Krebs solution at 37°C containing in (meq/liter): Na`150; K+ 4.0; Mg2`2.0; Ca2`2.4; C1-136; H2PO4 0.9; HCO 11.0; and glucose 5.0 mmol/liter. Buffer was oxygenated by continuous gassing with 95% 02/5% CO2 and maintained at 37°C (pH 7.30-7.35). The buffer was made acidic (pH 6.6) by gassing with 75% 02/25% CO2. The glass used for making the microelectrodes for pressure microinjection was washed in boiling ethanol, rinsed several times with distilled water, and dried. Microelectrodes were pulled on a Brown-Flaming electrode puller (Sutter Instrument Co., San Francisco, CA) with a narrow box filament (1.5 mm) to construct a tapered tip convenient for pressure microinjection. When filled with 1 M KCI, the microelectrodes exhibited resistances ranging from 30 to 60 MQI. The microelectrodes were beveled with a WPI beveling system (W-P Instruments, Inc., New Haven, CT) to facilitate penetration of the cells and delivery of fluid during pressure application. Beveled and filled microelectrodes exhibited resistances of <20 Mg.
Pressure microinjection was performed with a Picospritzer system (General Valve Corp., Fairfield, NJ) that permits rapid and reproducible ejectiQn of picoliter volumes from the microelectrodes while intracellular action potentials are recorded simultaneously. The Picospritzer was connected to a compressed nitrogen tank. Pressure and injection time were regulated under the control ofa solenoid-operated three-way valve, which when inactivated cqnnected the microelectrode to atmospheric pressure, and when activated, permitted the application ofa positive pressure pulse (up to 100 psi) to the microelectrode. The microelectrode was held in a WPI micropipette holder that provided a leak-proof seal and was positioned with a Narishige micromanipulator (Narishige Scientific Instrument Laboratory, Tokyo, Japan). Simultaneous intracellular action potential recording and injection were accomplished with the same microelectrode. Microelectrodes were calibrated with a microscopic ocular micrometer yielding measurements of the diameter of droplets released into mineral oil under increasing pressure and pulse duration. The volume delivered by pressure injection was linearly related to pulse duration as shown in Fig. 1 . Electrophysiologic data obtained during pressure microinjection were accepted for analysis only when the calibration curves prior to and after the injections were reproducible. Signals were processed sequentially through a high-impedance unity gain electrometer (WPI, -a J--j 0 model M4A), a constant-gain operational amplifier (x 50), and a variablegain amplifier before storage on FM analogue tape. Action potential recordings, stored on analogue tape, were analyzed off-line with an automated system (18) .
Assuming that the volume injected into the cytosol is similar to that released in mineral oil during calibration and that the LPC diffuses freely throughout the cell as shown previously by autoradiography (13), we estimated the augmentation of the intracellular concentration of LPC achieved. Cell volume was calculated to be 0.1 nl based on a cylindrical cell model with a 20-,um radius and 100 MAm length (1.26 X 101 gim3 or 0.1 nl). In most experiments intracellular injection was initiated at a low pressure which was gradually increased.
Experiments performed to validate the pressure microinjection system involved intracellular injection ofcyclic AMP into canine Purkinje cells. The microelectrode was back-filled with a solution of KCI (1 M) containing cyclic AMP (1 M), and the microelectrode was calibrated by injection into mineral oil. After continuous acquisition of intracellular recordings had been documented, the cells were depolarized by superfusion with Krebs buffer containing 10 mM KCI to inactivate the fast sodium channel. They were then injected with cyclic AMP to activate the slow inward current (Fig. 2) The chest was opened with a median sternotomy, and the pericardium was incised along the anterior interventricular sulcus. Care was taken to prevent contamination of the cardiac lymph with blood by avoiding bleeding from the pericardium. Evan's Blue dye (0.5%, 100 Ml) was injected into the left ventricular subepicardium at the apex to permit visualization of the cardiac lymphatics, usually evident within 5 min after injection of dye. Careful dissection of the cardiac lymph node, situated between the superior caval vein and brachiocephalic artery, exposed the cardiac lymph vessels. All visibly stained vessels were carefully ligated with 5-0 silk. A 22 G intravenous, teflon placement unit (Deseret Medical, Inc., Sandy, UT) was inserted toward the heart into the largest lymphatic vessel caudal to the node. The end ofthe catheter was cut and connected to polyethylene tubing (PE-60, Clay Adams, Parsippany, NJ) filled with heparin. No heparin was given systemically. A 5-0 silk suture was placed around the catheter to avoid dislodgement while lymph was subsequently collected.
The left anterior descending (LAD) coronary artery was isolated just proximal to the first diagonal branch with care to avoid interference with flow in the lymphatic vessels coursing adjacent to the coronary artery.
A 2-0 silk suture was placed loosely around the coronary artery so that it could be occluded by clamping a snare of polyethylene tubing onto the suture.
After the lymph had become transparent as residual dye was cleared, lymph was collected continuously in glass tubes on ice containing 3.8% sodium citrate as an anticoagulant. Samples were collected every 15 min and volumes recorded. After a 1-h control period, the LAD coronary artery was ligated for 2 h. Lymph was collected every 15 min throughout the 2-h interval of ischemia. Lymph samples were frozen rapidly (-70°C) for subsequent extraction and quantification ofphospholipids and protein.
At the end of the 2-h interval of ischemia, the tissue was reperfused for 1-h, and Evan's Blue dye was injected again into the left ventricular apex with simultaneous collection ofthe cardiac lymph until the lymph became dark blue confirming that the collected lymph had originated from the ischemic region.
An additional four dogs served as sham operated controls and were prepared similarly except that the LAD coronary artery was not ligated. Cardiac lymph was collected every 15 min for 2 h.
Several methodologic problems required evaluation. Supracardiac lymph originates not only from the heart but also from the pericardium, mediastinal tissue, and lung (19) . Extracardiac contributions could dilute an increase in lysophosphoglycerides attributable to drainage of an ischemic region of the heart. In addition, influx of fluid into the lymph vessels from the extralymphatic space could occur (16) . Furthermore, the composition of cardiac lymph could be altered by passage through the pretracheal lymph node (20, 21) which harbors cells, including lymphocytes, known to contain phospholipases (22) and lysolecithin-acyl transferase (23) . Previous results from our laboratory obtained with 9'Tcsulfur colloid injected into selected intramural layers of the heart and serial imaging with a scintillation camera indicate that lymph from anterior regions of the heart, supplied by the LAD coronary artery, drains consistently into the cardiac lymph node (24) .
To assess the extent of dilution of cardiac lymph, experiments were performed with simultaneous cannulation of the anterior intraventricular epicardial lymph vessel that receives input from the anterior region of the heart supplied by the LAD coronary artery. Cannulation of the epicardial lymph vessel was performed with a 30G needle attached to flexible polyethylene tubing (PE 10 (25) , filtered, and separated into classes based on the composition of the polar headgroup with high performance liquid chromatography as previously described (26, 27) . Fractions corresponding to each phospholipid class were collected and quantified by microphosphate assay after ashing with 10% MgNO3 in ethanol (27) . Total protein content was determined by the dye binding method of Bradford (28) . Protein components of lymph were separated by electrophoresis on agarose gel at pH 8.6 and stained with amido black, and individual fractions were quantified by scanning densitometry.
Because choline phospholipids in canine sarcolemma contain -60% plasmalogens (29) , experiments were performed to determine whether the LPC fraction in lymph contained lysoplasmalogen. The fatty acid composition of choline phospholipids in 0.5-1.0 ml samples of lymph collected during the control period or during the first 45 min following coronary occlusion was assessed after extraction and HPLC separation ofthe phospholipids into classes based on polar headgroup composition. The PC and LPC fractions were collected and the solvent contents removed by evaporation under a stream of N2 gas. The phospholipid contents were then hydrolyzed in I ml MeOH/HCI at 90°C for 90 min and neutralized with Na2CO3 (solid). The fatty acid methyl esters (FAME) and/or dimethylacetal (DMA) products were extracted three times successively with I ml of heptane. The heptane layers were combined and then dried over Mg2SO4, filtered, and injected onto a 30-mm X 0.25-mm fused silica capillary gas-chromatography column coated with SP2330 with a split ratio of 5-10:1. Sample constituents were eluted isothermally at 190°C with a Varian model 3700 chromatography system (Varian Associates, Inc., Palo Alto, CA) with helium as a carrier gas at a flow rate of 2 ml/min. Components eluting from the column were detected and quantified with a flame ionization detector and Varian 4270 integrator. FAME and DMA molecular species in effluents from the column were identified by comparison of the retention time and electron-impact mass spectrum with results obtained following injection of commercially available FAME standards and DMA derivatives prepared from myocardial sarcolemma as described previously (29) .
Statistics. Previous results froin our laboratory have indicated that a reduction of extracellular pH to 6.7 results in a threefold increase in the sensitivity ofPurkinje fibers to the electrophysiologic effects of extracellular LPC (5, 9). Furthermore, it inhibits the activity of lysophospholipase (30) , the cytosolic enzyme primarily responsible for metabolism of LPC. Accordingly, as shown in Fig.  3 , 50 mM LPC was injected into canine Purkinje cells at pH 6.6 Reduction of pH to 6.6 by itself did not induce significant electrophysiologic alterations. In the experiment illustrated, the application of 40 psi pressure for 1 s was sufficient to eject 1 pl of the 50 mM LPC microelectrode solution. Because the volume of a canine Purkinje cell is -100 pl, the estimated augmentation of the intracellular concentration of LPC was 500 uM. Nevertheless, no significant electrophysiologic changes were seen (Fig.  3) . The data from 18 experiments are shown in Table I were seen. Likewise, injection of a similar volume ofthe vehicle alone failed to induce electrophysiologic effects. Phospholipids in cardiac lymph. The flow rate of cardiac lymph from the supracardiac vessel was variable, ranging from 0.6 to 8.7 ml/h with a mean of 2.3±0.4 ml/h (n = 23). Lymph flow from the supracardiac lymph vessel during the 1-h control period and 2 h of ischemia is shown in Fig. 4 . Because of the variability of lymph flow from animal to animal, the results were normalized with respect to control flow calculated as the mean flow of the first four 15-min samples. In four sham-operated dogs, lymph flow rate did not change significantly throughout a 2-h collection interval (Fig. 4) . In animals with ischemia, cardiac lymph flow gradually decreased by 21±8%. The decrease of lymph flow with ischemia became significant (P < 0.01) 1 h after its onset (Fig. 4) .
Recovery of phospholipids from cardiac lymph was assessed by adding LPC and PC standards to samples prior to extraction. Recovery was 97-99% for both phospholipids (n = 5). To sel reflects constituents not only from the heart but also from lung, pericardium, and mediastinum. Its composition may change as it passes through the pretracheal lymph node. However, the phospholipid composition of samples of lymph from the epicardial lymph vessel on the anterior portion of the heart in six control dogs was virtually indistinguishable from that of lymph from the supracardiac lymph vessel (Table III) . Alterations of the composition ofphospholipids in cardiac lymph associated with ischemia and reperfusion. Changes in the concentrations of LPC and PC in supracardiac lymph with 2 h of ischemia are shown in Fig. 5 . LPC increased by 13% within 15 min ofthe onset ofischemia. The increase may have occurred even earlier, but the small volume oflymph available protracted the initial sampling interval required to 15 min. A peak increase of concentration of LPC appeared consistently within 30 min and averaged 118% of control values (Fig. 5) . This peak contrasted with a decrease of the concentration of LPC seen in corresponding intervals in sham-operated controls (Fig. 5) . The initial increase was followed by a decline through the first hour of ischemia and by no change during the second hour.
In contrast to the significant increase in the concentration of LPC in cardiac lymph, there were no significant changes in the concentrations in cardiac lymph of the other phospholipids assayed during the time course of ischemia (Fig. 5) .
To Fig. 6 ). In contrast, there was no significant increase in the net efflux of PC or any of the other phospholipids assayed. The (Fig. 6) .
Thus, despite the potential dilutional effects of lymph flow from nonischemic regions and extramyocardial sources that could mask changes in concentration and efflux of LPC, significant increases in the concentration and efflux of LPC were seen early after the onset ofischemia. To assess the extent ofdilution, Evan's Blue dye was infused continuously into the ventricular tissue at the apex in a region to be rendered ischemic later (see Methods). The concentration of dye was 7.5-fold higher in the epicardial lymph sample compared to that measured in supracardiac lymph. In another similar experiment the calculated dilution factor was 8.8. Assuming that the increase ofconcentration of LPC with ischemia is attributable exclusively to changes in the ischemic region, the observed 18% increase of LPC in supracardiac lymph would reflect an actual increase of 7. lymph from normal animals was 84±5 ,uM (Table III) , comparable to that in control, supracardiac lymph prior to coronary occlusion (79±0.4 MM) (Table III) . Based on a dilutional factor of 7.5 and a net observed 18% increase in the concentration of LPC, the actual concentration of LPC in interstitial fluid of the ischemic zone was calculated to be 197 ,uM.
The concentration of LPC required to induce electrophysiologic effects is dependent in part on the concentration of protein in the medium (9) . Protein composition of serum and cardiac lymph in control conditions and with ischemia is shown in Table  IV . The concentration of total protein in control, nonischemic lymph was 20% lower than that in normal serum. Albumin content of normal cardiac lymph was 1.58 g/100 ml in contrast to 1.44 g/100 ml with ischemia. Although total protein decreases slightly (i.e., by 10%o) during ischemia, the fractional contribution of albumin does not change. Thus, although the concentration of LPC increases in lymph from ischemic regions, the concentrations of protein and of albumin do not and, in fact, may decline.
In an effort to identify the subcellular locus or loci for the generation of lysophospholipids in canine cardiac lymph during ischemia, we compared the distribution of molecular species of PC and LPC present in lymph collected during the control and ischemic conditions from the same animal. The characteristic distribution of PC molecular species in myocardial sarcolemma may differ substantially from that of PC in lymph. If this were the case, the measurement of the distribution of the LPC molecular species in lymph during both the control and ischemic intervals should provide indirect criteria relevant to the question of whether the increase in LPC during ischemia represents LPC generated in situ from sarcolemma or LPC arising from extramyocytic sources. In order to collect sufficient LPC for duplicate analysis oflymph from ischemic zones, it was necessary to combine all samples collected from a given animal during the first 45-min interval after coronary occlusion. The results demonstrate that choline phospholipids in cardiac lymph consist exclusively of 0-acyl ester species with no vinyl-ethers (Table V) .
The presence of substantial (>10%) amounts of phospholipid species which contain alkyl-ether groups that are not hydrolyzed by conventional methods employing HCl/MeOH (31) was excluded by the lack of demonstrable amounts of LPC remaining after hydrolysis of PC or LPC with MeOH/HCl after TLC separation and I2 staining of extracts of the reaction mixtures. Be- First, lymph flow within the ischemic region was assumed not to increase during the time course of ischemia. Based on direct measurements, total lymph flow fell slightly with ischemia though significantly decreasing only after 1 h. In experiments performed to determine directly the concentration of LPC in epicardial lymph, the flow decreased markedly during the 1-h ischemic interval. Thus, during ischemia, epicardial lymph flow decreased rather than increased. The second assumption was that the increase in LPC measured from the supracardiac lymph vessel represented changes dependent exclusively on constituents liberated from the ischemic zone. Previous results from our laboratory indicate that the increase in tissue LPC occurs in ischemic but not normal zones of the same heart (7). Thus, it is unlikely that the increases of concentration and efflux of LPC in the supracardiac lymph vessel early after ischemia were attributable to sites other than the ischemic zone. The observations that lymph flow in the epicardial vessel decreased markedly during the first 30 min of ischemia without a significant decrease of lymph flow in the supracardiac lymph vessel despite an increase in both the concentration and efflux of LPC in supracardiac lymph indicate that the concentration of LPC in the ischemic zone is likely to be even higher than that calculated.
Although the site ofproduction oflysophospholipids in ischemic tissue has not yet been elucidated, these metabolites appear to accumulate in the extracellular space. LPC increases twofold in venular effluents from ischemic regions within 10 min (5).
The fact that electrophysiologic derangements induced by ischemia are rapidly reversible with reperfusion even in the presence of maintained hypoxia (3) suggests that accumulation of metabolites in the extracellular compartment is a critical determinant of the electrophysiologic alterations seen. The fact that venular blood from ischemic regions induces marked electro-physiologic alterations in normoxic tissue in vitro (2) suggests that accumulation is, at least in part, extracellular. The results of the present study add further support to the likelihood of an extracellular site ofaccumulation. In lymph obtained early after the onset of ischemia, the concentration of LPC is sufficient to induce marked electrophysiologic changes. The fact that the LPC present in lymph during control conditions and with ischemia did not contain choline lysoplasmalogens further supports the conclusion that the lysophospholipids in lymph from ischemic zones are not derived from the sarcolemma. Accordingly, the enhanced production or decreased catabolism ofLPC may reflect metabolism in vascular smooth muscle, endothelium or, alternatively, in blood cell elements. However, the identification of a phospholipase A2 specific for plasmalogens in canine myocardium (32) suggests that the absence of lysoplasmalogens with ischemia may reflect an activation of phospholipase A2 specific for acyl ester PC as opposed to plasmalogens. Thus, the absence of lysoplasmalogen in lymph does not preclude the possibility that LPC may be derived from a myocytic as opposed to an extramyocytic source.
Because ofthe slow transit of lymph from the ischemic zone to the supracardiac lymph vessel as well as dilution with fluid from noncardiac sources, it was not possible to directly compare the changes in the concentration of LPC in lymph with the occurrence of arrhythmias. All animals developed arrhythmias within the first 5 min ofischemia, but the severity of ventricular arrhythmias was unrelated to the magnitude of the increase of LPC. It is likely that the extent ofheterogeneity ofaccumulation in interstitium within the ischemic zone, with resultant heterogeneous electrophysiologic alterations, is a critical factor in arrhythmogenesis.
Several observations suggest that lymphatic drainage removes metabolites that contribute to arrhythmogenesis in ischemic myocardium. For example, Rusznyak and colleagues (33) have reported that obstruction ofcardiac lymphatics leads to marked changes in the electrocardiogram analogous to those occurring with ischemia including ST-segment depression or elevation, increase in T-wave amplitude, and deep Q waves. Szlavy and colleagues (34) have reported that injection of cardiac lymph obtained from ischemic but not normal hearts into coronary arteries in dogs results in arrhythmias and alterations in the electrocardiogram analogous to those seen with ischemia in vivo. Thus, ischemia appears to elaborate arrhythmogenic metabolites in cardiac lymph. The results of the present study suggest that one such metabolite is LPC. Based on anatomical studies, Uhley and colleagues (35) have hypothesized that cardiac lymphatics may contribute to the development of pathologic lesions of the conduction system either by direct involvement or indirectly by delivering toxic metabolites from a remote, damaged area to the conduction pathways.
The present results demonstrate also that intracellular accumulation of LPC at relatively high concentrations fails to induce electrophysiologic derangements analogous to those seen with extracellular delivery. Extracellular delivery of concentrations of LPC as low as 20-50 ,uM induce profound and reversible electrophysiologic effects (7-10, 12) associated with incorporation of <1% of total sarcolemmal phospholipid based on measurements of radiolabeled LPC and electron microscopic autoradiography (13, 14) . Despite calculated intracellular concentrations of LPC as high as 500 ,M after pressure microinjection, no apparent electrophysiologic alterations were induced. Thus, either intracellular binding preventing access of LPC to the sarcolemma, intracellular catabolism preventing marked accumulation, or delivery from the cytosolic rather than extracellular side of the sarcolemma precludes marked electrophysiologic perturbations.
The intracellular binding protein in heart (Z protein) can bind both fatty acids and fatty acid esters depending on its molecular state (36) . Binding of LPC to this protein is likely, judging from the amphipathic structure of LPC and its avid binding to other proteins, including albumin. Intracellular membranes, excluding sarcolemma, comprise -95% ofthe cellular membrane surfaces. Because LPC is readily incorporated into cell membranes, it is likely that much ofthe injected LPC is incorporated into other cell membrane systems, including the sarcoplasmic reticulum and mitochondria, thereby reducing availability of free LPC for incorporation into the sarcolemma. However, because of the small volumes of injectate that could be made into a single cell, it was not possible to directly measure the subcellular distribution of injected LPC. Previous findings after extracellular delivery of radiolabeled LPC and subsequent electron microscopic autoradiography indicate that LPC diffuses rapidly throughout the intracellular compartment (13, 14) . Thus, intracellular injection of LPC would likely result in rapid diffusion throughout the intracellular compartment as well.
Intracellular catabolism of LPC could have occurred and accounted for the lack of a potent electrophysiologic effect. However, the major cytosolic catabolic enzyme in heart, lysophospholipase, is inhibited markedly (i.e., 88%) by a reduction in pH to 6.6 (30) , and all injection experiments were performed at this pH. Thus, it is unlikely that intracellular catabolism completely obviated the high levels of intracellular LPC.
It is unlikely also that delivery from the cytosolic side of the sarcolemma would fail to induce electrophysiologic effects analogous to those induced by delivery from the extracellular space if the extent of sarcolemmal incorporation were similar. This conclusion is supported by the very rapid transsarcolemmal movement of LPC (13) . Thus, the predilection of extracellular lysophosphoglycerides to induce potent electrophysiologic effects appears to reflect differential binding of intracellular compared with extracellular lysophosphoglycerides.
Although the specific ionic events responsible for the electrophysiologic effects induced by lysophospholipids are not yet clear, several pertinent observations have been made. The rapid inward current carried by Na+ is depressed judging from very rapid reductions in Vmax associated with a downward and rightward shift of the membrane response curve (8, 10) . Thus, gNa+ appears to be reduced not only as a result of the associated decrease in resting potential but also directly through the interaction of LPC with the sarcolemma. The decrease ofresting membrane potential induced by LPC appears to reflect a reduction in outward K+ conductance (12). The slow inward current carried by calcium appears to be reduced in magnitude by LPC (12) although intracellular calcium appears to increase with an associated increase in contractility (12, 37) . This effect of LPC may be secondary to inhibition of sarcolemmal Na+-K+ ATPase (38, 39) with accumulation of intracellular sodium and enhanced Na'-Ca2' exchange. Thus, the electrophysiologic effects of LPC delivered from the extracellular compartment appear to be secondary to a reduction in the membrane conductances to Na+, K+, and Ca2+.
In conclusion, the present findings indicate that extracellular LPC is a more direct determinant ofelectrophysiologic derangements than intracellular LPC. With myocardial ischemia in vivo, significant changes are seen in lymphatic fluid indicative of increased concentrations of LPC impinging on the external surface of sarcolemma. These results suggest that pharmacologic interventions designed to inhibit the accumulation of lysophospholipids are likely to be effective as antiarrhythmic interventions particularly if they act preferentially on the extracellular loci responsible for increased production of LPC. Recent observations from our laboratory indicate that intracellular accumulation of long-chain acyl carnitines contributes to the electrophysiologic effects ofhypoxia in cultured myocytes (40) . Ifsimilar phenomena occur with ischemia in vivo, the effects of intracellular long-chain acyl carnitines and extracellular lysophosphoglycerides may be additive in view ofthe known additive nature of their electrophysiologic effects in vitro (9, 15) .
